Connect with us


The FDA’s Latest Eyecare Recall Involves Barefoot Workers at a Production Facility

Kilitch Healthcare India officially issued a recall of 27 brands and formulations of lubricating eyedrops.




The FDA’s Latest Eyecare Recall Involves Barefoot Workers at a Production Facility

National pharmacy chains in October were among a host of outlets to remove dozens of eyecare products from their shelves due to potential contamination concerns.

Now the Indian company behind those products, Kilitch Healthcare, has officially issued a voluntary recall of 27 brands and formulations of lubricating eyedrops.

The move came after the U.S. Food and Drug Administration recently toured the Kilitch Healthcare India manufacturing facility in Mumbia where the products were produced. U.S. health inspectors uncovered a host of sanitation and manufacturing problems during their visit. Among the issues documented were barefoot workers, altered records, and cracked floors.

According to a story by The Associated Press, an FDA report on the facility included “factory workers not wearing masks, gloves and gowns and working barefoot in areas that are supposed to be sterile. A manager told FDA officials ‘that this is their standard practice.’”

The FDA also uncovered evidence that factory officials falsified contaminated test results or outright omitted results on a routine basis. A microbiologist who works at the facility said erroneous reporting of sterility tests happed, “two or three times per month.”

Eyedrops from the factory were sold at CVS Health, Walgreens, Rite-Aid, Walmart, and Target, among others. A full list of effected products is available here.


From the FDA

For those patients who use these products, there is a potential risk of eye infections or related harm. These products are intended to be sterile. Ophthalmic drug products pose a potential heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses. To date, Kilitch Healthcare India Limited has not received any reports of adverse events related to this recall.

FDA encourages health care professionals and patients to report adverse events or quality problems with any medicine to FDA’s MedWatch Adverse Event Reporting program:

  • Complete and submit the report online at Medwatch; or
  • Download and complete the form, then submit it via fax at 1-800-FDA-0178.



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular